Patel, K., Dhakal, B., Kaur, G., Maziarz, R., Callander, N., Sperling, A., Schinke, C., Jakubowiak, A., Biran, N., Sborov, D., Varga, C., Anderson, L., Deol, A., Kanate, A., Kocoglu, M., Solh, M., Banerjee, K., Rana, K., Kostic, A., Granados, E., Jackson, C., Heery, C., Freeman, C. L., Welliver, T., Frigault, M. (2025). Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: Updated results from iMMagine–1. Blood. https://doi.org/10.1182/blood-2025-256